Sensex jumps 250 pts; pharma & IT stocks rally, Divis Labs zooms

Divis Laboratories Update by Epic ResearchDivis Laboratories Update by Epic Research

Divis Labs surged more than 15 percent intraday as the US Food & Drug Administration will lift import alert 99-32 on the company’s unit-II at Visakhapatnam.

The USFDA had issued an Import Alert under clauses 99-32 and 66-40 in March of 2017 and a warning letter in May of 2017 for Vishakhapatnam facility.

Divi’s Laboratories had filed a detailed responses and given updates to the Form-483 and the warning letter within the stipulated time.

For more information ✆ – 0731-6642300 or Visit http://www.epicresearch.co

Facebook Twitter YouTube Pinterest Linkedin Google+

You may also like:

Sensex turns sluggish, Nifty still holds 9300; ICICI falls ahead of Q4' width= Sensex consolidates ahead of FOMC meet outcome; RBL Bank most active' width=
Sensex turns sluggish, Nifty still holds 9300; ICICI falls ahead of Q4 Sensex consolidates ahead of FOMC meet outcome; RBL Bank most active
Share Button

About the Author

Epic Research
Epic Research
Epic Research - Investment Adviser is a leading financial services provider with presence in Indian and other global capital markets. Call on - 0731-664-2300